Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.#ImmunomodulationAI researchClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studySystematic reviewPeer review unconfirmed

Role of Cytokines and MMPs in Multiple Sclerosis Pathogenesis

A systematic review identified key cytokines (like IL-3, IL-5, IL-6, and MMPs) as critical drivers of neuroinflammation and neurodegeneration in multiple sclerosis (MS). MMP-1 could differentiate early MS from clinically isolated syndrome, while IL-9, IL-10, and IL-13 may be targets for neuroprotective strategies.

What this does not proveThe findings do not confirm any treatment effectiveness and lack clinical trial data for validation.
#Biomarkers#Cytokines#Immunomodulation#NeuroprotectionRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42794509AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studySystematic reviewPeer-reviewed

Human studies on α7-nAChR activation in MS

A systematic review indicates that activation of the α7-nAChR may lead to reduced inflammation and support nerve resilience in the central nervous system (CNS).

What this does not proveHowever, there are challenges to translating these findings into clinical practice, such as receptor desensitization and the absence of validated biomarkers.
#Immunomodulation#Neuroprotection#DMTsRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42790772AI summary of a published abstract. Not medical advice.